Literature DB >> 392593

Advances in the use of iron-chelating agents for the treatment of iron overload.

B Modell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 392593

Source DB:  PubMed          Journal:  Prog Hematol        ISSN: 0079-6301


× No keyword cloud information.
  12 in total

1.  Specific hemoperfusion through agarose acrobeads.

Authors:  S Margel; L Marcus
Journal:  Appl Biochem Biotechnol       Date:  1986-02       Impact factor: 2.926

Review 2.  Recent advances in haematology.

Authors:  D Samson; I Chanarin; C D Reid
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

3.  Survival and desferrioxamine in thalassaemia major.

Authors:  B Modell; E A Letsky; D M Flynn; R Peto; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

4.  Irradiation for progressive paraparesis in B-thalassemia intermedia.

Authors:  J J Wilson; M E Hill; J H Crookston
Journal:  Can Med Assoc J       Date:  1980-12-06       Impact factor: 8.262

5.  Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection.

Authors:  S Schubert; I B Autenrieth
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

6.  Effects of iron and desferrioxamine on Rhizopus infection.

Authors:  F Abe; H Inaba; T Katoh; M Hotchi
Journal:  Mycopathologia       Date:  1990-05       Impact factor: 2.574

7.  Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.

Authors:  R M Robins-Browne; J K Prpic
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

8.  Comparison of siderophore production and utilization in pathogenic and environmental isolates of Yersinia enterocolitica.

Authors:  C E Chambers; P A Sokol
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Tinnitus in a patient with beta-thalassaemia intermedia on long-term treatment with desferrioxamine.

Authors:  M N Marsh; I B Holbrook; C Clark; J L Shaffer
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

10.  Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.

Authors:  P Cossu; C Toccafondi; F Vardeu; G Sanna; F Frau; R Lobrano; G Cornacchia; A Nucaro; F Bertolino; A Loi; S De Virgiliis; A Cao
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.